MedPAC sharpens its criticism of Medicare’s MIPS program
Medicare’s Merit-based Incentive Payment System has landed in an uncomfortable place: widely used, widely tolerated, and sharply criticized by the federal advisory panel charged with judging whether it actually works. Members of the Medicare Payment Advisory Commission described a system that consumes practice time, distributes only tiny financial rewards, and offers patients little information they can meaningfully use at the bedside or when choosing care.
The complaint is not that physicians should be exempt from measurement. The complaint is that the current structure asks clinicians to navigate a heavy administrative apparatus in exchange for incentives so small that they may barely register against the operational costs of reporting. For practices already stretched by staffing shortages, billing complexity, prior authorization, and the demands of Medicare participation, another layer of scoring can feel less like quality improvement and more like a compliance tax.
Physicians working under Medicare do need some sort of quality measurement. MedPAC’s position is that the measurement framework should be simpler, more reliable, and more closely tied to what patients and clinicians can actually act on. In other words, quality reporting only earns its place if it changes care, improves accountability, or both.
One sentence captures the tension: the program rewards almost everyone, but the reward is tiny.
Small bonuses do little to change clinical behavior
The underlying problem with MIPS is not difficult to see. When a program is designed to influence behavior through payment, its incentives must be strong enough to matter. If the financial upside is modest, practices can spend hours documenting and attesting without ever feeling a meaningful clinical or operational return. That weak link between effort and reward makes the system look busy rather than useful.
That dynamic also shapes how physicians experience the program day to day. Quality measurement can be defensible when it is concise, clinically credible, and tied to outcomes that improve decisions. It becomes far harder to justify when it asks clinicians to chase points through reporting mechanics that are opaque to patients and exhausting for staff. The result is a system that can feel more like scorekeeping than medicine.
For patients, the stakes are different but equally important. A quality program should help them understand which clinicians deliver better care, which practices coordinate effectively, and where safety or performance gaps are most concerning. MedPAC’s critique suggests that MIPS falls short on that front as well, because the program tells patients little they can use. If the public cannot interpret the results, the accountability loop breaks at the point where transparency should matter most.
Why a simpler quality model may be more credible
The commission’s call for a simpler approach reflects a basic truth of clinical administration: measurement works best when it is credible, stable, and directly connected to outcomes. A sprawling reporting framework may generate data, but data alone do not guarantee insight. In the case of physician payment, the target should be a structure that captures meaningful performance without forcing practices to divert disproportionate energy away from patient care.
A leaner model would also be easier to defend in principle. Clinicians are more likely to accept quality oversight when the rules are understandable and when the metrics avoid needless duplication. If the measurement burden becomes too large, physicians may view the system as detached from actual care delivery, and that perception can erode trust in the program itself.
The conversation around MIPS is really a conversation about signal and noise. A quality system should amplify the signal: outcomes, coordination, safety, and reliability. When the administrative noise grows louder than the signal, the program starts consuming resources without producing the kind of feedback that improves practice.
Medicare still needs measurement, but not this much machinery
MedPAC’s criticism lands at a moment when Medicare continues to search for ways to connect payment, value, and accountability. That search is legitimate. Fee-for-service medicine can reward volume without necessarily rewarding better care, and public programs have every reason to ask whether physician payment can be aligned more closely with performance.
Yet the commission’s stance makes plain that alignment alone is not enough. A program can be well intentioned and still become too cumbersome to justify. It can generate penalties and bonuses without providing enough clinical direction to patients or enough meaningful incentive to physicians. It can survive on paper while failing to earn respect in exam rooms and billing offices.
For practices, the practical consequence is familiar: more documentation, more workflow disruption, and more attention diverted from direct care. For policymakers, the question is whether MIPS has crossed the line from a quality program into a bureaucracy that measures extensively but changes little. The critique from MedPAC points squarely in that direction.
The commission is not arguing against quality measurement itself. It is arguing against a version of measurement that is expensive to administer, weakly motivating, and difficult for patients to use. That is a narrow but consequential distinction, because the future of Medicare physician payment may depend on whether regulators can design a replacement that avoids repeating the same mistakes under a different name.